Parallax Volatility Advisers, L.P. Agenus Inc Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $45,546 - $83,155	-18,899 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $41,010 - $59,342	18,899 New	18,899 $48,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $13,247 - $19,686	-5,278 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $8,392 - $14,039	5,278 New	5,278 $13,000
Q1 2018 May 15, 2018	SELL	$3.51 - $6.04 $39,361 - $67,732	-11,214 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $36,557 - $53,602	11,214	11,214 $37,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.